Blunted expression of miR-199a-5p in regulatory T cells of patients with chronic obstructive pulmonary disease compared to unaffected smokers
Authors:
Open Access
- 9 June 2014
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 177 (1) , 341-352
Abstract
Summary: Chronic obstructive pulmonary disease (COPD) is characterized by an abnormal regulatory T cell (Treg) response and increases in T helper type 1 (Th1) and Th17 cell responses. It is unclear if dysregulation of microRNAs (miRNA) within Treg cells contributes to the abnormal inflammatory response in COPD. In this study, we aimed to compare the miRNA profile of COPD Treg cells with that of healthy controls and to explore the function of differentially expressed miRNAs. We first obtained Treg and T effector cells (Teff) from peripheral blood of non-smokers, unaffected current smokers and COPD current smokers. Then, we assessed their miRNA expression by microarray analysis followed by real-time reverse transcription–polymerase chain reaction (RT–PCR) validation of particular miRNAs. Six and 96 miRNAs were expressed differentially in COPD Treg cells versus Treg cells of healthy non-smokers and healthy smokers, whereas no differences were found in miRNA expression in Teff cells. We found that miR-199a-5p was repressed by approximately fourfold in Treg cells of COPD patients compared to healthy smokers (P < 0·05). In addition, miR-199a-5p was over-expressed in Treg cells compared to Teff cells (P < 0·001) and had significant over-representation of its target genes in the Treg transcriptome, being associated with the transforming growth factor (TGF)-β activation pathway (P < 0·01). We also confirmed the function of miR-199a5p in an in-vitro loss-of-function cell model running TaqMan® arrays of the human TGF-β pathway. These findings suggest that the abnormal repression of miR-199a-5p in patients with COPD compared to unaffected smokers may be involved in modulating the adaptive immune balance in favour of a Th1 and Th17 response.Keywords
Funding Information
- NHLBI (5K08HL091058)
This publication has 35 references indexed in Scilit:
- Imbalance of Th17/Treg cells in mice with chronic cigarette smoke exposureInternational Immunopharmacology, 2012
- Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-β signalling pathwayNucleic Acids Research, 2012
- Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ TregsClinical Immunology, 2010
- Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 ResponsesCell, 2010
- Genome-Wide Identification of Human FOXP3 Target Genes in Natural Regulatory T CellsThe Journal of Immunology, 2010
- MicroRNA miR-199a* Regulates the MET Proto-oncogene and the Downstream Extracellular Signal-regulated Kinase 2 (ERK2)Journal of Biological Chemistry, 2008
- Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptorNature, 2008
- Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smokingEuropean Respiratory Journal, 2007
- CD4-Regulatory Cells in COPD PatientsChest, 2007
- Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax, 2002